Overview
BiotechPhase 3psilocybinDMT
Nonprofit conducting Phase 2 psilocybin trials for MDD. Open-source approach.
Visit WebsiteMadison, WI
5
Clinical Trials
2014
Founded
30
Employees
0
Open Roles
Open Positions
No open positions at this time
Research Areas
Clinical Pipeline(5)
Terminated·N/A·psilocybin
PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
No intervention will be administered as part of this study.Major Depressive Disorder
Completed·Phase 1·DMT
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
5-methoxy-N,N-dimethyltryptamine succinate saltPharmacokinetics
Active, Not Recruiting·Phase 3·psilocybin
Psilocybin for Major Depressive Disorder (MDD)
Psilocybin 25 mgDepressive Disorder, Major
Completed·Phase 1·psilocybin
An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics
PsilocybinQTc Interval
Completed·Phase 2·psilocybin
A Study of Psilocybin for Major Depressive Disorder (MDD)
PsilocybinDepressive Disorder, Major